Xconomy National

Archives

by in

Entry	Author	Date	Location
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News	Erin Kutz	02/03/12	Boston
FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis	Arlene Weintraub	01/30/12	Boston
Genentech Seeks FDA Clearance for Next Skin Cancer Drug	Luke Timmerman	09/12/11	San Francisco
Curis and Genentech Unleash the Hedgehog to Fight a Deadly Skin Cancer	Arlene Weintraub	06/28/11	Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News	Erin Kutz	06/24/11	Boston
Genentech, Curis Pass Clinical Trial With Skin Cancer Drug, Look Ahead to FDA	Luke Timmerman	06/20/11	San Francisco
Alnylam Sued By Tekmira, Curis Cancer Drug Shows Results, Still River Gets $11.5M, & More Boston-Area Life Sciences News	Erin Kutz	03/25/11	Boston
Genentech Gets Positive Result in Cancer Trial	Ryan McBride	03/21/11	Boston
Curis Misses Mark in Cancer Drug Trial, Genzyme Re-Elects Full Board, GTC Cuts Jobs, & More Boston-Area Life Sciences News	Erin Kutz	06/18/10	Boston
Curis Stock Tanks After Cancer Drug Fails in Roche, Genentech’s Hands	Luke Timmerman	06/16/10	Boston
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten	Luke Timmerman	10/08/09	Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter	Luke Timmerman	03/17/09	Boston
Curis Gets $3M From Genentech For Ovarian Cancer Trial Initiation	Luke Timmerman	12/08/08	Boston
Hold on Tight: Biotech Execs Predict Hard Times for Industry as Cash Dwindles	Luke Timmerman	11/25/08	National
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter	Luke Timmerman	11/25/08	Boston
Curis Begins Phase 1 Trial of Anti-Tumor Drug	Ryan McBride	08/26/08	Boston
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News	Rebecca Zacks	05/07/08	Boston
Let the Epic Curing Begin: Epix and Curis Earn Milestone Payments	Erik Mellgren	05/05/08	Boston
Exact Sciences Makes the List, Curis and Alkermes Get Dropped, Patent Reform Sparks Debate, & More Life Sciences News	Rebecca Zacks	03/12/08	Boston
Curis, Alkermes Down on News of Failed Pharma Partnerships	Rebecca Zacks	03/10/08	Boston
Cleaning the Slate, Raising Funds, and Filling the Executive Suite	Rebecca Zacks	08/13/07	Boston
Page 1 of 1